Skip to content

Clinical trials

Phase 3 Opioid-Induced Constipation trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Opioid-Induced Constipation Phase: Phase 3 Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20075
20092
20103
20115
20121
20136
20171
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Terminated8
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca5
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)4
Sucampo Pharma Americas, LLC4
Bausch Health Americas, Inc.3
Shionogi3
Novartis2
CMC Ambroise Paré1
Develco Pharma Schweiz AG1
Shire1
St. John Health System, Michigan1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Opioid-Induced Constipation25
Constipation9
Bronchiolitis Obliterans Syndrome4
Pain4
Cancer Pain1

Trials

Showing 26 to 25 of 25. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.